0LO3 Stock Overview
Veeva Systems Inc. provides cloud-based software for the life sciences industry.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0LO3 from our risk checks.
Veeva Systems Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$199.96 |
| 52 Week High | US$236.99 |
| 52 Week Low | US$160.60 |
| Beta | 0.73 |
| 1 Month Change | -12.86% |
| 3 Month Change | -1.50% |
| 1 Year Change | 9.22% |
| 3 Year Change | -27.08% |
| 5 Year Change | 46.02% |
| Change since IPO | 227.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0LO3 | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | -5.3% | 0.5% | 0.4% |
| 1Y | 9.2% | 66.6% | -1.0% |
Return vs Industry: 0LO3 underperformed the UK Healthcare Services industry which returned 66.6% over the past year.
Return vs Market: 0LO3 exceeded the UK Market which returned -1% over the past year.
Price Volatility
| 0LO3 volatility | |
|---|---|
| 0LO3 Average Weekly Movement | 3.4% |
| Healthcare Services Industry Average Movement | 7.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0LO3 has not had significant price volatility in the past 3 months.
Volatility Over Time: 0LO3's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 7,172 | Peter Gassner | www.veeva.com |
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process.
Veeva Systems Inc. Fundamentals Summary
| 0LO3 fundamental statistics | |
|---|---|
| Market cap | US$32.34b |
| Earnings (TTM) | US$525.71m |
| Revenue (TTM) | US$2.36b |
61.2x
P/E Ratio13.6x
P/S RatioIs 0LO3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0LO3 income statement (TTM) | |
|---|---|
| Revenue | US$2.36b |
| Cost of Revenue | US$677.29m |
| Gross Profit | US$1.69b |
| Other Expenses | US$1.16b |
| Earnings | US$525.71m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.26 |
| Gross Margin | 71.35% |
| Net Profit Margin | 22.24% |
| Debt/Equity Ratio | 0% |
How did 0LO3 perform over the long term?
See historical performance and comparison